M.N.B. Company

What M.N.B. Company does

M.N.B. Company is a privately held pharmaceutical toll manufacturer founded in 2007 and headquartered in Alexandria, Egypt. The company specializes in prescription pharmaceuticals, food supplements, topical skin care and OTC products, producing more than 20 branded SKUs across five therapeutic categories: Orthopedics (e.g., Glucomine, Osteorapid, Damine, Calvid), Surgery (Cripple Cream), Dermatology (Cripple, Selfora line, Whitbiel, Notrechole, Selfora Anti-Lice), Gynecology (Femivit, Femipause, Senfy line, Valifresh), and Pediatrics (Cripple D, B-CARE). Manufacturing is conducted at GMP-certified sites in Egypt and a Queen award-accredited site in the United Kingdom, with active GCC product registrations across multiple SKUs.

The business operates a B2B toll manufacturing model, distributing finished pharmaceutical and OTC products through healthcare providers and pharmacies across eight markets: Egypt, the United Arab Emirates (including a regional headquarters in RAK FTZ and a Scientific Office in Dubai Healthcare City), Bahrain, Qatar, the United Kingdom, Saudi Arabia, Iraq and Kuwait. Its stated go-to-market is enterprise field sales targeting a broad horizontal segmentation of medical specialties, supported by participation in major regional healthcare exhibitions (Arab Health, Africa Health, Medic East/West Africa). Pricing is not publicly disclosed and revenue is not reported. MNB positions itself as a cost-competitive alternative to multinational pharma with high ethical and quality standards, and aims to rank among the top 20 toll manufacturers in the MENA region.

Name

M.N.B. Company

Legal name

M.N.B. Company

Website

https://mnbco.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

51–100 employees

Short description

M.N.B. Company is a privately held Egyptian pharmaceutical toll manufacturer, founded in 2007, producing prescription drugs, food supplements, topical skin care and OTC products across five therapeutic categories for healthcare providers in eight MENA and UK markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Toll Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)

akta.pro secondary industries

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH), Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Pharmaceutical & Medical Plastic Packaging Manufacturing (IMANAEAK)

Keywords

• Pharmaceutical toll manufacturing
• Prescription pharmaceuticals
• OTC topical products
• Food supplements manufacturing
• Dermatology and orthopedic medicines

Headquarters

HQ city

Alexandria

HQ country

Egypt

HQ region

Africa

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Toll Manufacturing: MNB Company operates as a toll manufacturing company producing pharmaceutical products, food supplements, topical skin care and O.T.C. products for distribution across their market territories in MENA region.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

M.N.B. Company is a pharmaceutical toll manufacturer that produces prescription pharmaceuticals, food supplements, topical skin care and OTC products across five therapeutic categories: Orthopedics, Surgery, Dermatology, Gynecology and Pediatrics. Manufacturing is carried out at GMP-certified facilities in Egypt and a Queen award-accredited facility in the United Kingdom, with GCC registration for marketed products. The company supplies healthcare providers and pharmacies across the MENA region (Egypt, UAE, Bahrain, Qatar, Saudi Arabia, Iraq, Kuwait) and the United Kingdom.

Product overview

M.N.B. Company is a toll manufacturing pharmaceutical company specializing in prescription pharmaceuticals, food supplements, topical, skin care and O.T.C. products since 2007. The company operates across five therapeutic product categories: ORTHOPEDICS (Glucomine, Glucomine Gel, Osteorapid, Damine, DAMINE D, Calvid, CALVID S), SURGERY (Cripple Cream), DERMATOLOGY (Cripple, Selfora Lotion, Selfora Shampoo, Whitbiel, SELFORA ANTI-LICE, NOTRECHOLE), GYNECOLOGY (Femivit, Femipause, Cripple N.C, Valifresh, Senfy, Senfy m Gel, Senfy F Gel, FEMIVIT H), and PEDIATRICS (Cripple D, B-CARE). Products include prescription medications and OTC topical treatments, manufactured at sites in Egypt and the United Kingdom with GMP certifications and GCC registration.

Differentiator

Problem solved

Functional benefit

Products and services

• Glucomine Tablets Glucomine Tablets are an orthopedic prescription medication for osteoarthritis treatment containing Glucosamine 1500 mg and Vitamin C 12 mg, supplied in packs of 30 or 60 tablets with a 24-month shelf life. Targeted at orthopedic prescribers and patients with osteoarthritis.
• Glucomine Gel Glucomine Gel is an orthopedic topical treatment for osteoarthritis containing Glucosamine Sulphate, Chondroitin Sulphate and MSM, supplied in a 50 gm tube. Targeted at orthopedic patients needing topical joint care.
• Osteorapid Osteorapid is an orthopedic gel with anti-edema, anti-inflammatory and analgesic properties containing Aescin, Methyl salicylate, Thymoquinone and Gamma linolinic acid; manufactured in the United Kingdom. For orthopedic prescribers and patients requiring topical pain/inflammation relief.
• Damine Damine is a Vitamin D supplement for Vitamin D deficiency treatment containing Vitamin D 50,000 IU, supplied in 50-tablet packs with a 24-month shelf life. Targeted at prescribers treating deficiency states.
• DAMINE D DAMINE D contains Vitamin D 14,000 IU in 50-tablet packs for daily Vitamin D requirements, stored at normal temperature conditions. Targeted at patients needing daily Vitamin D supplementation.
• Calvid Calvid provides daily Calcium and Vitamin D supplementation with Ca 500 mg and Vit D 2,000 IU in 20 effervescent tablets. Targeted at patients with calcium/Vitamin D insufficiency.
• CALVID S CALVID S contains Ca 500 mg plus Vit D 5,000 IU in 20 effervescent tablets for calcium and Vitamin D deficiency treatment, with a 36-month shelf life; manufactured in the United Kingdom. Targeted at prescribers managing deficiency states.
• Cripple Cream Cripple Cream is a surgical/post-operative care cream containing Aloe Vera, Panthenol, Chamomile, Dimethicone, Wheat germ oil, Allantoin and Honey for moisturizing skin care and skin rejuvenation. Targeted at surgical patients in post-operative recovery.
• Cripple (Dermatology) Cripple is a dermatological moisturizing skin care cream containing Aloe Vera, Panthenol, Chamomile, Dimethicone, Wheat germ oil, Allantoin and Honey; helps maintain healthy skin and restores damaged or irritated skin. Targeted at dermatology patients needing skin repair.
• Selfora Lotion Selfora Lotion is a hair strengthening lotion containing Burdock Extract, Jojoba, Aloe Vera, Wheat germ, Rosemary, Panthenol and Olive oil, supplied in 120 ml bottles with a 36-month shelf life. Targeted at patients with hair thinning or scalp concerns.
• Selfora Shampoo Selfora Shampoo is an anti-dandruff shampoo containing Octopiros, Coal Tar, Panthenol, Chamomile and Rosemary, supplied in 120 ml bottles with a 36-month shelf life. Targeted at patients with dandruff/scalp conditions.
• Whitbiel Whitbiel is a dermatological whitening cream containing Liquorice Extract, Bearberry Extract, Parsley Extract and Aloe Vera Oil, applied twice daily in 50 gm tubes. Targeted at patients seeking skin tone evening.
• SELFORA ANTI-LICE SELFORA ANTI-LICE is an anti-lice lotion containing Cyclomethicone, Parsley, Fennel, Neem, Tea tree, Rosemary and Olive oil, supplied in 120 ml bottles with a 2-year shelf life. Targeted at families/patients managing head lice.
• NOTRECHOLE NOTRECHOLE is a stretch marks eraser cream containing Cocoa butter, Tamanu Oil, Panthenol, Dimethicone and Capric triglyceride, applied twice daily in 50 gm tubes. Targeted at patients with stretch marks/skin scarring.
• Femivit Femivit is a gynecological multivitamin supplement supplied in 30-tablet packs with a 24-month shelf life, manufactured in the United Kingdom. Targeted at gynecological patients needing multivitamin support.
• Femipause Femipause is a multivitamin product for menopause supplied in a 30-tablet pack, manufactured in the United Kingdom. Targeted at women in menopause requiring multivitamin support.
• Cripple N.C Cripple N.C is a gynecological cream for nipple cracks containing Cocoa Butter, Panthenol, Chamomile, Dimethicone and Allantoin, applied twice daily in 50 gm tubes. Targeted at nursing mothers with nipple irritation.
• Valifresh Valifresh is an intimate feminine wash containing Chlorhexidine, Triclosan, Chamomile, Thyme and Rose oil, supplied in 200 ml bottles stored at normal temperature conditions. Targeted at women seeking intimate hygiene.
• Senfy Senfy is an intimate feminine wash containing Chlorhexidine, Triclosan, Thyme, Chamomile, Menthol and Rose oil, supplied in 200 ml bottles, applied once daily with a 36-month shelf life. Targeted at women seeking daily intimate hygiene.
• Senfy m Gel Senfy m Gel is an intimate gel for men containing a sterile gel formulation, applied as needed with a 36-month shelf life. Targeted at men seeking intimate hygiene support.
• Senfy F Gel Senfy F Gel is an intimate feminine gel containing Curcuma Extract, Pomegranate Peel Extract, Aloe Vera and Lavender oil, available in 50 gm and 75 gm tubes with a 36-month shelf life. Targeted at women seeking intimate care.
• FEMIVIT H FEMIVIT H is a multivitamin supplement for pregnancy containing multi vitamins in 30-tablet packs, applied once daily with a 2-year shelf life; manufactured in the UK and registered in GCC. Targeted at pregnant women needing multivitamin support.
• Cripple D Cripple D is a pediatric diaper rash cream containing Zinc oxide, Aloe Vera, Chamomile, Panthenol and Olive oil, packaged in 50 gm tubes with outer cartons, 36-month shelf life, manufactured in Egypt. Targeted at infants with diaper rash.
• B-CARE B-CARE is a pediatric product for relief of flatulence, colic and spasmodic conditions in children containing Chamomile, Peppermint, Anise and Thyme, supplied in packs of 10 sachets with a 2-year shelf life, registered in GCC. Targeted at pediatric patients with colic/spasmodic conditions.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered minor and core.

• The Principle TrustminorOthersThe Principle Trust is a non-profit foundation located in UK, aiming to provide a holiday retreat for children and their families who are disadvantaged socially, physically, emotionally or as a result of extreme poverty. MNB provides long-term sponsorship through yearly contributions.
• Children's Cancer Hospital Egypt 57357 (CCHE)coreOthersChildren's Cancer Hospital Egypt 57357 is the largest children's cancer hospital in the world. MNB has long-term sponsorship through periodic donations and has organized events to help children feel care and love from others.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Hikma Pharmaceuticals: Jordan-headquartered multinational pharmaceutical manufacturer with a major branded and generics portfolio across MENA and injectable manufacturing operations. Comparable as a MENA-based pharmaceutical manufacturer operating toll/contract capacity and competing for the same brand-customer wallet, though at substantially larger scale.
• Cipla: Indian-headquartered global pharmaceutical manufacturer with a large generics, OTC, and API portfolio and significant presence in emerging markets including MENA and Africa. Comparable to MNB as a generics and OTC manufacturer competing for the same third-party manufacturing and distribution opportunities in MENA.
• Aurobindo Pharma: Indian multinational pharmaceutical company with one of the largest generic and contract manufacturing footprints globally, including MENA distribution. Comparable to MNB as a low-cost generics and contract manufacturer targeting similar therapeutic and OTC categories in emerging markets.

Direct peers

• EIPICO (Egyptian Pharmaceutical Industries Company): One of Egypt's largest pharmaceutical manufacturers producing generics, OTCs, and supplements for local and export markets. Directly comparable to MNB as an Egyptian-domiciled pharma manufacturer serving similar therapeutic categories and distribution channels in MENA.
• Eva Pharma: Egypt-based pharmaceutical company manufacturing generics, food supplements, and OTC products with strong MENA export presence. Comparable to MNB in product mix (Rx, OTC, supplements), therapeutic breadth, and regional distribution footprint.
• Amoun Pharmaceutical: Leading Egyptian pharmaceutical manufacturer of branded generics and OTC products across multiple therapeutic areas. Comparable as a domestic Egyptian manufacturer with similar therapeutic breadth (orthopedics, gynecology, dermatology) and MENA distribution.
• Pharco Pharmaceuticals: Egypt's largest pharmaceutical manufacturer by volume, producing generics, OTCs, and supplements for MENA and emerging markets. Comparable to MNB in product categories and Egyptian manufacturing base, though at substantially larger scale and broader therapeutic coverage.

Regional players

• Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer of generics and consumer health products with manufacturing operations across the GCC. Comparable to MNB as a GCC-headquartered pharma manufacturer serving overlapping regional markets, though primarily focused on UAE/GCC rather than the wider MENA footprint.
• SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): Saudi-listed pharmaceutical manufacturer producing branded generics, OTCs, and consumer health products for the Saudi and GCC markets. Comparable to MNB in product mix and GCC registration footprint, though based in Saudi Arabia rather than Egypt.
• Tabuk Pharmaceuticals: Saudi-headquartered pharmaceutical company manufacturing branded generics and OTC products for MENA markets. Comparable as a regional pharma manufacturer serving similar therapeutic categories, though anchored in Saudi rather than Egypt.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/Mnb_Company
• Facebookfacebook.com/M.N.B.Company
• LinkedInlinkedin.com/company/m-n-b-company

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about M.N.B. Company